AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home iLABMED Article
PDF (288.6 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Commentary | Open Access

Focus on lipoprotein(a): The time is now

Ya‐hui Lin, Qiong Yang, Zhou Zhou( )
Key Laboratory for Molecular Diagnostics of Cardiovascular Diseases, Center of Laboratory Medicine, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases, Beijing, China
Show Author Information

Keywords

lipoprotein (a)cardiovascular diseasesChinese populationlaboratory tests

References

[1]

Rosenson RS, Goonewardena SN. The residual risk Odyssey: from LDL to Lp(a). J Am Coll Cardiol. 2021;78(5):434–6. https://doi.org/10.1016/j.jacc.2021.04.103
Crossref Google Scholar
[2]

Reyes‐Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, et al. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42(1):e48–e60. https://doi.org/10.1161/ATV.0000000000000147
Crossref Google Scholar
[3]

Stefanutti C, Thompson GR. Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances. Curr Atherosclerosis Rep. 2015;17(1):465. https://doi.org/10.1007/s11883-014-0465-6
Crossref Google Scholar
[4]

Li JJ, Ma CS, Zhao D, Yan XW. Lipoprotein(a) and cardiovascular disease in Chinese population: a Beijing Heart Society Expert Scientific Statement. JACC Asia. 2022;2(6):653–65. https://doi.org/10.1016/j.jacasi.2022.08.015
Crossref Google Scholar
[5]

Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J Clin Invest. 1994;93(6):2526–34. https://doi.org/10.1172/JCI117263
Crossref Google Scholar
[6]

Lanktree MB, Anand SS, Yusuf S, Hegele RA; SHARE Investigators. Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians. Circ Cardiovasc Genet. 2010;3(1):39–46. https://doi.org/10.1161/CIRCGENETICS.109.907642
Crossref Google Scholar
[7]

Liu Y, Ma H, Zhu Q, Zhang B, Yan H, Li H, et al. A genome‐wide association study on lipoprotein (a) levels and coronary artery disease severity in a Chinese population. J Lipid Res. 2019;60(8):1440–8. https://doi.org/10.1194/jlr.P091009
Crossref Google Scholar
iLABMED
Volume 1 Issue 2,
September 2023
Pages 99-102
DOI: 10.1002/ila2.19
Cite this article:
Lin Y, Yang Q, Zhou Z. Focus on lipoprotein(a): The time is now. iLABMED, 2023, 1(2): 99-102. https://doi.org/10.1002/ila2.19

672

Views

101

Downloads

1

Crossref

Altmetrics
Published: 19 July 2023
© 2023 The Authors. Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Return